Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$26,000.00

Mechanism of cell protection by oxytocin

FY 2012-13

Summary
Oxytocin (OT) plays numerous functions in the body in addition to the labor induction and stimulation of milk ejection. We reported that OT and OT receptors are also found in the heart in some rodents, and the hormone may play a role in the embryonal development of the heart by promoting cardiomyocyte differentiation. OT plays important role in the protection of the heart in ischemic conditions. In vitro, OT changes cell metabolism and augments glucose uptake by cardiomyocytes via phosphoinositide-3-kinase and potentiates the glucose uptake in hypoxia targeting the mitochondria. Because of the central role of mitochondria in governing cell death/survival decisions, it seems likely that the mechanism of OT protection may be related to mitochondrial injury. Therefore, we will investigate on isolated mitochondria whether functional OT receptors are present on mitochondrial inner membranes and whether they are colocalized with endogenous peptide in preconditioned or OT transgenic cell lines. Then, using specific inhibitors of kinases and by analysis of protein phosphorylation we will investigate the signaling involved in OT-mediated cell protection. We also accumulated evidences that OT treatment reduced apoptosis in the mesenchymal stem cells (MSCs) exposed to hypoxia. The protection was transmitted from OT-preconditioned MSCs to cardiomyocytes in co-culture. OT treatment of MSCs can change the cell phenotype and provoke differentiation of these stem cells to cardiomyocytes. Here we also propose that OT-preconditioning of MSCs enhances secretion of therapeutic growth factors and also stimulate production of RNA-containing microparticles (MiRs). MiRs are cells post-transcriptional regulators of gene expression that can act as end-effectors of signalization pathways. Therefore, we propose the experimental approaches based on OT treatment of MSCs that augment or attenuate microRNA levels. Altogether, the proposed experiments will enhance our knowledge about cardiomyocyte resistance in ischemic conditions and cardiomyogenic differentiation of stem cells. This will provide the molecular basis for utilization of OT in protection of cardiac cells.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
238803-2012
Name nom
Gutkowska, Jolanta
Department département
Médecine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5102
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Inter-cellular communication
Research subject fr
Communication inter-cellulaire
Partie
1
Nb partie
1
Application title
Mechanism of cell protection by oxytocin
Keyword
NSERC
Application summary
Oxytocin (OT) plays numerous functions in the body in addition to the labor induction and stimulation of milk ejection. We reported that OT and OT receptors are also found in the heart in some rodents, and the hormone may play a role in the embryonal development of the heart by promoting cardiomyocyte differentiation. OT plays important role in the protection of the heart in ischemic conditions. In vitro, OT changes cell metabolism and augments glucose uptake by cardiomyocytes via phosphoinositide-3-kinase and potentiates the glucose uptake in hypoxia targeting the mitochondria. Because of the central role of mitochondria in governing cell death/survival decisions, it seems likely that the mechanism of OT protection may be related to mitochondrial injury. Therefore, we will investigate on isolated mitochondria whether functional OT receptors are present on mitochondrial inner membranes and whether they are colocalized with endogenous peptide in preconditioned or OT transgenic cell lines. Then, using specific inhibitors of kinases and by analysis of protein phosphorylation we will investigate the signaling involved in OT-mediated cell protection. We also accumulated evidences that OT treatment reduced apoptosis in the mesenchymal stem cells (MSCs) exposed to hypoxia. The protection was transmitted from OT-preconditioned MSCs to cardiomyocytes in co-culture. OT treatment of MSCs can change the cell phenotype and provoke differentiation of these stem cells to cardiomyocytes. Here we also propose that OT-preconditioning of MSCs enhances secretion of therapeutic growth factors and also stimulate production of RNA-containing microparticles (MiRs). MiRs are cells post-transcriptional regulators of gene expression that can act as end-effectors of signalization pathways. Therefore, we propose the experimental approaches based on OT treatment of MSCs that augment or attenuate microRNA levels. Altogether, the proposed experiments will enhance our knowledge about cardiomyocyte resistance in ischemic conditions and cardiomyogenic differentiation of stem cells. This will provide the molecular basis for utilization of OT in protection of cardiac cells.